Recognition

 

Awards and Milestones

We are an early-stage Pittsburgh-based biopharma company in the pre-product stage.

  • Awarded a $225,000 DARPA Phase I SBIR/STTR. submitted in 2018; funds released in Q1-2019

  • 2019 Tech-Connect World Innovation Award: Selected among the top 15% tech companies from global academic technology transfer offices, SBIR/STTR awardees, and early-stage companies.

  • 2019 Defense TechConnect Innovation Award: Recognized within the top 15% of submitted technologies as ranked by the Selection Committee. Rankings are based on the potential positive impact the submitted technology will have for the warfighter and national security.

  • Accepted into Carnegie Mellon’s startup Incubator in 2019

  • Developed prototype in 2019

  • Submitted provisional patent in Q2-2020

  • Accepted into NSF iCorps Program at Carnegie Mellon University in 2020

  • Accepted into Swartz Center for Entrepreneurship Venture Bridge Program in 2020

  • Accepted into JP Morgan Accelerator Bundle Program

  • Closed a $1M pre-seed round in 2020

  • Completed in-house audit of quality management system in Q4-2020